Movement, page-2

I don't think your the only one to feel that way.

This is from the SMH today. Though analysts get it wrong as often as anyone else.

"Some prominent money managers and forecasts said the selling has gone too far, too fast. Jonathan Golub, chief market strategist at RBC Capital Markets, says the bloodbath in biotechnology and tech stocks is temporary, and investors should buy back the best performers of 2015."